BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22825324)

  • 1. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media.
    Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
    Otol Neurotol; 2012 Sep; 33(7):1218-24. PubMed ID: 22825324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
    Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
    Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y; Usubuchi H; Kodama K; Kanazawa H; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.
    Kanazawa H; Yoshida N; Shinnabe A; Iino Y
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):88-92. PubMed ID: 24863399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
    Iino Y; Takahashi E; Ida S; Kikuchi S
    Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant.
    Han YE; Kang YS; Cho Y; Park MK
    J Int Adv Otol; 2018 Apr; 14(1):144-147. PubMed ID: 29764789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Nagamine H; Kakizaki K; Komiya T; Katano H; Saruya S; Kodera K
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IgE in eosinophilic otitis media.
    Iino Y
    Allergol Int; 2010 Sep; 59(3):233-238. PubMed ID: 20657163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Usubuchi H; Kodama K; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H; Yoshida N; Yamamoto H; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Iino Y
    Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comments on 'Anti-IgE therapy for eosinophilic disorders'.
    Salihoglu M; Karabacak E; Kutlu A; Haholu A
    Otol Neurotol; 2014 Jan; 35(1):190-1. PubMed ID: 24335936
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to the comments on "Anti-IgE therapy for eosinophilic disorders".
    Iino Y
    Otol Neurotol; 2014 Jan; 35(1):191. PubMed ID: 24270719
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study.
    Maselli DJ; Singh H; Diaz J; Peters JI
    Ann Allergy Asthma Immunol; 2013 Jun; 110(6):457-61. PubMed ID: 23706716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab.
    Suzaki I; Kimura Y; Tanaka A; Hirano K; Ishibashi A; Mizuyoshi T; Ando I; Kitajima T; Watanabe S; Hinohira Y; Kobayashi H
    Auris Nasus Larynx; 2019 Feb; 46(1):141-146. PubMed ID: 29909018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights into Eosinophilic Otitis Media.
    Kanazawa H; Yoshida N; Iino Y
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media.
    Uchimizu H; Matsuwaki Y; Kato M; Otori N; Kojima H
    Allergol Int; 2015 Sep; 64 Suppl():S18-23. PubMed ID: 26344075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Sekine Y; Yoshida S; Kikuchi S
    Auris Nasus Larynx; 2021 Jun; 48(3):353-360. PubMed ID: 32943257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study.
    Dal Negro RW; Guerriero M; Micheletto C; Tognella S; Visconti M
    J Asthma; 2011 Jun; 48(5):437-41. PubMed ID: 21599560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.